Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Am J Hematol. 2012 Jun 20;87(10):953–956. doi: 10.1002/ajh.23280

Table III.

Cytokine Response to 852A

Patient IP-10 (sensitivity 10pg/ml) (mean ±SD) IFN-γ (sensitivity 10pg/ml) (mean ±SD)
Pre-therapy Peak Time to Peak (days) Pre-therapy Peak Time to Peak (days)

A 587.7 ±10.9 2398.9 ±155.9 4 1.3 ±0.6 2.5 ±1.7 4
B 1011.5 ±8.9 1618.4 ±34.0 4 4.4 ±0.3 10.3 ±2.6 4
C 1517.7 ±13.8 1517.7 ±13.8 0 1.6 ±0.8 4.2 ±2.3 83
D 3054.1 ±84.1 23,002.8 ±2445.1 3 7.0 ±0.6 72.7 ±1.2 3
HHS Vulnerability Disclosure